Johnson initially considered building an implantable brain-computer interface but chose non-invasive Flow instead because: (1) implants take ~10 years development + 10 years trials = 20 years to market through slow healthcare system; (2) non-invasive technologies will iterate faster and reach market first; (3) non-invasive systems can utilize full human sensory modalities for brain inputs, whereas implants are spatially restricted.